TIMELINESS

Ariti S.A. joins the Your Pharma Partner in Europe Network of Companies

Ariti is pleased to announce its accession to the Your Pharma Partner in Europe (YPP) network, further strengthening its strategic presence in the European pharmaceutical sector and expanding its opportunities for developing new partnerships. Your Pharma Partner in Europe is an alliance of independent pharmaceutical companies established to support pharmaceutical…

Read MoreAriti S.A. joins the Your Pharma Partner in Europe Network of Companies

Ayrmid and Ariti Sign Distribution Agreement for Omisirge® in Greece and Cyprus

LONDON – February [2], 2026 – Ayrmid, Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., today announced that it has entered into an exclusive distribution agreement with Ariti S.A., a Greece based pharmaceutical company for the  distribution of Omisirge (Omidubicel-onlv) in Greece and Cyprus. Under the terms of…

Read MoreAyrmid and Ariti Sign Distribution Agreement for Omisirge® in Greece and Cyprus

New Collaboration in the Pharmaceutical Sector of Ariti & Insmed Ireland Limited

Ariti S.A and Insmed Ireland Limited recently signed an agreement for the Greek territory, aiming at increasing awareness of non-tuberculosis mycobacteria pulmonary disease. This agreement marks an important milestone for the pharmaceutical business unit of Ariti as it not only reinforces the current portfolio of its activities but enhances its…

Read MoreNew Collaboration in the Pharmaceutical Sector of Ariti & Insmed Ireland Limited

ARITI’s distinction in Diamonds of the Greek Economy 2019

The presentation of the Diamonds of the Greek Economy 2019 Business Excellence Awards took place on July 10, 2019, at the Grande Bretagne Hotel Athens with the presence of over 600 businesspeople and business representatives. Among the awardees, ARITI S.A. was honored with the Business Excellence Award “The Most Admired…

Read MoreARITI’s distinction in Diamonds of the Greek Economy 2019